Despite advances in pharmaceutical and technological development, cancer continues to be a life-threatening illness globally. In addition to other specialized procedures, radiotherapy, chemotherapy, and surgery are methods used to treat cancer. However, in recent years, natural products have either been used as food su...
Tooba Jabeen, S. Akram, Matloob Ahmad et al.· Biomolecules· 0 citations
Diabetes mellitus remains a major global health challenge, necessitating the development of new therapeutic agents targeting key enzymes involved in carbohydrate metabolism. In this study, ten novel imidazo-thiazole-thiazolidinone hybrids were designed, synthesized and their structural integrity was confirmed through 1...
S. Bano, Shoaib Khan, Sampath Chinnam et al.· Bioorganic chemistry (Print)· 0 citations
Cancer remains a major global health challenge and one of the leading causes of mortality worldwide. In the present study, a new series of fused nitrogen-containing heterocyclic derivatives was synthesized from a pyridine-based pyrimidinethione key synthon. Hydrazinolysis followed by cyclo-condensation and condensation...
S. K. Ramadan, Ali H. Abdelrahman, M. Hegazy et al.· RSC Advances· 0 citations
Current in silico drug discovery workflows largely rely on ligand-based screening and structure-based molecular docking to identify enzyme inhibitors, often overlooking dynamic biological contexts that influence drug efficacy and stability. Integrating multiscale computational modeling with experimental validation at e...
Zanib Fiaz, Shoaib Khan, Tayyiaba Iqbal et al.· RSC Medicinal Chemistry· 0 citations
Nitrogen-fused heterocycles have attracted considerable research interest in pharmaceutical, medicinal, organometallic, and materials chemistry. In this work, two new series of quinazoline-linked thiazolo[3,2-a]pyrimidines and their cyclic chalcone derivatives were synthesized using choline hydroxide as an environmenta...
S. M. Gomha, Sami A. Alhussain, Yaser A. M. Sulaiman et al.· RSC Advances· 0 citations
7f is identified as a promising lead displaying concurrent EGFR and COX-2 inhibitory activity together with pronounced antiproliferative effects, consistent with its experimentally observed dual inhibitory activity.
Abdullah Alkhammash, B. A. Saleem, Khulood H. Oudah et al.· RSC Advances· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.